Cargando…

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies

Vaginal laser therapy is a non-hormonal treatment option for vulvovaginal atrophy (VVA), a component of the genitourinary syndrome of menopause. Through a microablative and/or thermal effect on atrophic vaginal epithelium, laser therapy activates growth factors that increase vascularity and collagen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salcedo, Félix Lugo, Blanco, Zuramis Estrada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337587/ https://www.ncbi.nlm.nih.gov/pubmed/32670377 http://dx.doi.org/10.7573/dic.2020-3-7

Ejemplares similares

Experience with ospemifene in patients with vulvar and vaginal atrophy and urinary incontinence: case studies
por: Blanco, Zuramis Estrada, et al.
Publicado: (2020)

Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study
por: Rodríguez, Silvia Pilar González
Publicado: (2020)

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy
por: Shin, Jae Jun, et al.
Publicado: (2017)

Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases
por: Goldstein, Andrew T., et al.
Publicado: (2016)

Experience with ospemifene in patients with vulvar and vaginal atrophy and associated sexual dysfunction: case studies
por: López, Ana Rosa Jurado, et al.
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles
por: del Carmen Pingarrón Santofimia, María, et al.
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy and a history of breast cancer: case studies
por: Lilue, Mariella, et al.
Publicado: (2020)

Ospemifene for vulvar and vaginal atrophy: an overview
por: Palacios, Santiago
Publicado: (2020)

Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis
por: Simon, James A., et al.
Publicado: (2023)

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy
por: Nappi, R. E., et al.
Publicado: (2015)

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy
por: Bruyniks, N., et al.
Publicado: (2016)

Update on alternative therapies for vulvovaginal atrophy
por: Chollet, Janet A
Publicado: (2011)

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy
por: Goldstein, S. R., et al.
Publicado: (2014)

Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy
por: Palacios, Santiago, et al.
Publicado: (2016)

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
por: Cagnacci, Angelo, et al.
Publicado: (2020)

Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast
por: Soe, Lin H, et al.
Publicado: (2013)

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
por: Wurz, Gregory T, et al.
Publicado: (2014)

Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2021)

Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
por: Sarmento, Ayane Cristine Alves, et al.
Publicado: (2021)

A systematic review of laser therapy for vulvovaginal atrophy/genitourinary syndrome of menopause in breast cancer survivors
por: Knight, Charity, et al.
Publicado: (2019)

Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
por: Parish, Sharon J, et al.
Publicado: (2013)

Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy
por: Diedrich, Chantal M., et al.
Publicado: (2019)

Effect of Ospemifene on Densitometric and Plasma Bone Metabolism Biomarkers in Postmenopausal Women Reporting Vulvar and Vaginal Atrophy (VVA)
por: Maffei, Silvia, et al.
Publicado: (2022)

Fractional CO(2) laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women
por: Arroyo, César
Publicado: (2017)

Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up
por: Ghanbari, Zinat, et al.
Publicado: (2020)

Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause
por: Kamronrithisorn, Thawinee, et al.
Publicado: (2020)

Treatment to External Labia and Vaginal Canal With CO(2) Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women
por: Samuels, Julene B, et al.
Publicado: (2019)

Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
por: Edwards, D., et al.
Publicado: (2016)

Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial
por: Constantine, G., et al.
Publicado: (2015)

Clinical Efficacy of Hormonal and Nonhormonal Agents in the Treatment of Vulvovaginal Atrophy
por: Ilhan, Gokcen, et al.
Publicado: (2021)

New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review
por: Benini, Vittoria, et al.
Publicado: (2022)

Vulvovaginal pyoderma gangrenosum in association with rituximab
por: Maloney, Catherine, et al.
Publicado: (2018)

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022)

Modulation of vulvovaginal atrophy (VVA) by Gelam honey in bilateral oophorectomized rats
por: Ismail, Nur Hilwani, et al.
Publicado: (2023)

A rare case of benign vulvovaginal leiomyoma: Case report and literature review
por: Ashraf Muhammed, Paxshan, et al.
Publicado: (2022)

Erosive Vulvovaginitis Associated With Borrelia burgdorferi Infection
por: Fesler, Melissa C., et al.
Publicado: (2019)

Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
por: Klumpp, Annika, et al.
Publicado: (2022)

Vulvovaginal Infralevator Haematoma Mimicking the Second Stage of Labour
por: Awoleke, J. O., et al.
Publicado: (2017)

First report of Vulvovaginitis due to Cryptococcus magnus in Iran
por: Ghajari, Ali, et al.
Publicado: (2018)

Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study
por: Garcia de Arriba, Susana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fki12dggtnpcfb285ih4djhd5k